Literature DB >> 25931413

Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes?

Giovanna Muscogiuri1, Vincenzo Nuzzo2, Adriano Gatti3, Alfonso Zuccoli2, Silvia Savastano4, Carolina Di Somma5, Rosario Pivonello4, Francesco Orio6,7, Annamaria Colao4.   

Abstract

Vitamin D (25(OH)D) levels have been associated with cardiovascular disease. Thus, the aim of our study was to investigate the association of 25(OH)D levels with coronary heart disease (CHD) in 698 consecutive type 2 diabetic outpatients. 698 consecutive type 2 diabetic outpatients (25.2 % men, age 66 ± 9 years) and 100 (90 % men, age 65 ± 13 years) age-matched non-diabetic volunteers were enrolled. 25(OH)D assay and the main cardiovascular risk factors were explored. 25(OH)D concentration was 22 ± 10 ng/ml in control subjects and 18.23 ± 10 ng/ml in diabetic patients (p < 0.01). The prevalence of hypovitaminosis D was higher in diabetic patients than in control subjects (90 vs. 83 %, p < 0.01). Diabetic subjects with hypovitaminosis D had higher prevalence of high values of A1C (p < 0.01), BMI (p < 0.01), LDL cholesterol (p < 0.01), triglycerides (p < 0.01), and glycemia (p < 0.01) than their vitamin D-sufficient counterparts. 25(OH)D and HDL cholesterol were lower (p < 0.01), while BMI (p < 0.01), age (p < 0.01), systolic (p < 0.01) and diastolic blood pressure (p < 0.01), diabetes duration (p < 0.01), A1C (p < 0.01), glycemia (p < 0.01), fibrinogen (p < 0.01), triglycerides (p < 0.01), and total (p < 0.01) and LDL cholesterol (p < 0.01) were higher in diabetic subjects with CHD than diabetic subjects without CHD. At the logistic regression analysis, the association of vitamin D with CHD was lost, while sex (p = 0.026), diabetes duration (p = 0.023), and age (p = 0.024) were the most powerful predictors of CHD. The current study demonstrates that 25(OH)D does not have a direct effect on CHD but may have an indirect effect mediated by cardiovascular risk factors such as diabetes duration, age, and sex.

Entities:  

Keywords:  Cardiovascular disease; Coronary heart disease; Hypovitaminosis D; Obesity; Type 2 diabetes; Vitamin D

Mesh:

Substances:

Year:  2015        PMID: 25931413     DOI: 10.1007/s12020-015-0609-7

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  33 in total

1.  Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative.

Authors:  Macarius M Donneyong; Carlton A Hornung; Kira C Taylor; Richard N Baumgartner; John A Myers; Charles B Eaton; Eiran Z Gorodeski; Liviu Klein; Lisa W Martin; James M Shikany; Yiqing Song; Wenjun Li; JoAnn E Manson
Journal:  Circ Heart Fail       Date:  2014-11-14       Impact factor: 8.790

2.  Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients.

Authors:  Massimo Cigolini; Maria Pina Iagulli; Valentino Miconi; Micaela Galiotto; Simonetta Lombardi; Giovanni Targher
Journal:  Diabetes Care       Date:  2006-03       Impact factor: 19.112

Review 3.  Vitamin D, thrombosis, and hemostasis: more than skin deep.

Authors:  Giovanni Targher; Isabella Pichiri; Giuseppe Lippi
Journal:  Semin Thromb Hemost       Date:  2012-02-07       Impact factor: 4.180

Review 4.  Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies.

Authors:  Lu Wang; Yiqing Song; Joann E Manson; Stefan Pilz; Winfried März; Karl Michaëlsson; Annamari Lundqvist; Simerjot K Jassal; Elizabeth Barrett-Connor; Cuilin Zhang; Charles B Eaton; Heidi T May; Jeffrey L Anderson; Howard D Sesso
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2012-11-13

5.  [25 hydroxyvitamin D levels and cardiovascular risk in a cohort of patients with advanced chronic kidney disease].

Authors:  C García-Cantón; E Bosch; I Auyanet; A Ramírez; P Rossique; C Culebras; A Sánchez; A Toledo; M Lago; Noemí Esparza; María Dolores Checa
Journal:  Nefrologia       Date:  2010       Impact factor: 2.033

Review 6.  Vitamin D and diabetes.

Authors:  Joanna Mitri; Anastassios G Pittas
Journal:  Endocrinol Metab Clin North Am       Date:  2013-12-12       Impact factor: 4.741

Review 7.  Vitamin D deficiency: a new risk factor for type 2 diabetes?.

Authors:  T Mezza; G Muscogiuri; G P Sorice; A Prioletta; E Salomone; A Pontecorvi; A Giaccari
Journal:  Ann Nutr Metab       Date:  2012-12-03       Impact factor: 3.374

Review 8.  Vitamin D and diabetes mellitus.

Authors:  Liviu G Danescu; Shiri Levy; Joseph Levy
Journal:  Endocrine       Date:  2008-11-01       Impact factor: 3.633

9.  Vitamin D levels and asymptomatic coronary artery disease in type 2 diabetic patients with elevated urinary albumin excretion rate.

Authors:  Christel Joergensen; Henrik Reinhard; Anne Schmedes; Peter R Hansen; Niels Wiinberg; Claus L Petersen; Kaj Winther; Hans-Henrik Parving; Peter K Jacobsen; Peter Rossing
Journal:  Diabetes Care       Date:  2011-10-31       Impact factor: 19.112

10.  The effect of high-dose vitamin D supplementation on insulin resistance and arterial stiffness in patients with type 2 diabetes.

Authors:  Ohk-Hyun Ryu; Wankyo Chung; Sungwha Lee; Kyung-Soon Hong; Moon-Gi Choi; Hyung Joon Yoo
Journal:  Korean J Intern Med       Date:  2014-08-28       Impact factor: 2.884

View more
  9 in total

Review 1.  Vitamin D status and cardiovascular outcome.

Authors:  F Saponaro; C Marcocci; R Zucchi
Journal:  J Endocrinol Invest       Date:  2019-06-06       Impact factor: 4.256

2.  The effects of vitamin D supplementation on proatherogenic inflammatory markers and carotid intima media thickness in subjects with metabolic syndrome: a randomized double-blind placebo-controlled clinical trial.

Authors:  Shabnam Salekzamani; Abolhassan Shakeri Bavil; Hossein Mehralizadeh; Mohammad Asghari Jafarabadi; Aymaral Ghezel; Bahram Pourghassem Gargari
Journal:  Endocrine       Date:  2017-05-16       Impact factor: 3.633

3.  Cardiovascular risk in adult hypopituitaric patients with growth hormone deficiency: is there a role for vitamin D?

Authors:  Maria Cristina Savanelli; Elisabetta Scarano; Giovanna Muscogiuri; Luigi Barrea; Laura Vuolo; Manila Rubino; Silvia Savastano; Annamaria Colao; Carolina Di Somma
Journal:  Endocrine       Date:  2015-10-29       Impact factor: 3.633

4.  Vitamin D-binding protein: one more piece in the puzzle of acromegalic osteopathy?

Authors:  G Mazziotti; F Maffezzoni; A Giustina
Journal:  Endocrine       Date:  2016-02-22       Impact factor: 3.633

5.  Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival.

Authors:  Federica Saponaro; Claudio Marcocci; Riccardo Zucchi; Concetta Prontera; Aldo Clerico; Marco Scalese; Sabina Frascarelli; Alessandro Saba; Claudio Passino
Journal:  Endocrine       Date:  2017-03-23       Impact factor: 3.633

6.  Calcitriol attenuates cardiac remodeling and dysfunction in a murine model of polycystic ovary syndrome.

Authors:  Ling Gao; Jia-Tian Cao; Yan Liang; Yi-Chao Zhao; Xian-Hua Lin; Xiao-Cui Li; Ya-Jing Tan; Jing-Yi Li; Cheng-Liang Zhou; Hai-Yan Xu; Jian-Zhong Sheng; He-Feng Huang
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

7.  The Association between Serum Vitamin D Concentration and New Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response (SIRI)-In Patients with Ischemic Heart Disease.

Authors:  Ewelina A Dziedzic; Jakub S Gąsior; Agnieszka Tuzimek; Marek Dąbrowski; Piotr Jankowski
Journal:  Nutrients       Date:  2022-10-10       Impact factor: 6.706

Review 8.  The Role of Vitamin D in Diabetes and Cardiovascular Disease: An Updated Review of the Literature.

Authors:  Dimitrios Papandreou; Zujaja-Tul-Noor Hamid
Journal:  Dis Markers       Date:  2015-10-20       Impact factor: 3.434

Review 9.  An Update on Vitamin D Metabolism.

Authors:  Federica Saponaro; Alessandro Saba; Riccardo Zucchi
Journal:  Int J Mol Sci       Date:  2020-09-08       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.